Latest 10-K
View 10-KStock Information
OTCQB: CDXI
Price
Change
Volume
52 week Low/High
Day Low/High
Company Overview
Cardax is a consumer health company focused on marketing ZanthoSyn®, a physician recommended astaxanthin dietary supplement for inflammatory health.* Cardax previously focused on development of pharmaceuticals for diseases driven by inflammation. Cardax may seek to monetize CDX-101, the Company's pre-clinical pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, and CDX-301, the Company's pre-clinical pharmaceutical candidate for macular degeneration.
Contact Information
Investor Relations
Cardax, Inc.
T: (808) 457-1400
investors@cardaxpharma.com
Transfer Agent
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598